Navigation Links
ShangPharma Announces Second Quarter 2011 Results
Date:8/22/2011

te effectively in its industry, which may subject it to increasing pricing pressure and reduce the demand for its services; expand and market its services and manage its growth; and develop and maintain effective internal control over financial reporting; as well as other risks outlined in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of this press release, and the Company does not undertake any obligation to update any such information, except as required under applicable law.

About Non-GAAP Financial Measures To supplement the Company's consolidated financial results presented in accordance with United States Generally Accepted Accounting Principles ("GAAP"), the Company uses the following non-GAAP financial measures: (1) gross profit, (2) gross margin, (3) profit from operations, (4) operating expenses, (5) operating margin, (6) net income, and (7) diluted earnings per ADS, each of which excludes expenses relating to or the effect of share-based compensation. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. For more information on these non-GAAP financial measures, please see the table captioned "Reconciliation of GAAP and non-GAAP Financial Data" set forth at the end of this press release.

The Company believes that these non-GAAP financial measures provide meaningful supplemental information regarding its operating performance by excluding expenses relating to or the effect of share-based compensation that may not be indicative of its operating performance. The Company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing its operating performance and when planning and forecasting future periods. These non-GAAP financial meas
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
2. ShangPharma Announces First Quarter 2011 Results
3. ShangPharma Corp. to Announce Fourth Quarter and Full Year 2010 Financial Results on March 15, 2011
4. Stem Cell Assurance, Inc. Announces Change of Name to BioRestorative Therapies, Inc.
5. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
6. Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
7. ACMG Announces New Online Live Learning Center: Will Bring Genetics and Genomics Education to Varied Health Professionals
8. Neurologix Announces Second Quarter 2011 Financial Results
9. Bion Announces New U.S. Patent for Phosphorus Removal
10. ViaCyte Announces Executive Management Changes
11. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015   St. Jude Children,s Research Hospital ... tool for finding genetic alterations that play an ... to identify with whole-genome sequencing. The findings appear ... . The tool is an algorithm ... Regression Tree in Next Generation Sequencing. ...
(Date:5/4/2015)... STONY BROOK, N.Y. , May 4, 2015 ... executed a $250,000 cooperative research and development agreement ... ) to advance the development of TRB-N0224 for ... companion animals, including dogs and cats.  Traverse Biosciences ... sublicense TRB-N0224 for the treatment and control of ...
(Date:5/4/2015)... , May 4, 2015  RegeneRx Biopharmaceuticals, Inc. ... that an independent team of researchers from ... Thymosin B4 (TB4) plays an important role in ... induced in an experimental mouse model, by promoting ... of damaged dermal tissue.  The research found that ...
(Date:5/4/2015)... 2015  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... unmet medical needs in the areas of inflammation, oncology ... preclinical data from three of its biodefense programs at ... Conference on May 12-14, 2015 to be held at ... St. Louis MO 63101. ...
Breaking Biology Technology:Scientists dramatically improve method for finding common genetic alterations in tumors 2Scientists dramatically improve method for finding common genetic alterations in tumors 3Scientists dramatically improve method for finding common genetic alterations in tumors 4Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 2Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 3Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 4Researchers Report that Thymosin B4 has a Major Role in Dermal Burn Wound Healing 2Researchers Report that Thymosin B4 has a Major Role in Dermal Burn Wound Healing 3Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 2Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 3Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 4Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 5Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 6Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 7Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 8Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 9Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 10Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 11Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 12
... ... has never been easier, or less smelly, thanks to a new indoor composting kit ... bucket collects food scraps in an airtight bucket. Bokashi, made using SCD,s probiotic technology, ... ...
... SANTA BARBARA, Calif. , May 17 ... the development and commercialization of breast cancer related applications of ... patents on the core technology that may be used for ... test, the Mammastatin Serum Assay (MSA). The patents are the ...
... 17 Three years of teamwork between Elekta and ... Ion Medical Center used carbon ion radiotherapy to treat a patient with ... Elekta,s treatment planning software, XiO® , for delivery with Mitsubishi Electric,s ... , , ...
Cached Biology Technology:All Seasons Indoor Composter™ and All Seasons Bokashi™ Provide Easy Way to Recycle Food Waste Right in Your Kitchen 2All Seasons Indoor Composter™ and All Seasons Bokashi™ Provide Easy Way to Recycle Food Waste Right in Your Kitchen 3Abviva Announces Further Patent Issuance for Technology Used in Breast Cancer Diagnostics and Therapeutics 2Abviva Announces Further Patent Issuance for Technology Used in Breast Cancer Diagnostics and Therapeutics 3Elekta / Mitsubishi Electric Collaboration Helps Japan's Gunma University Heavy Ion Medical Center Launch Advanced Carbon Ion Therapy for Treating Cancer 2
(Date:3/24/2015)... WASHINGTON , March 24, 2015   NexID ... applications with critical security-authentication needs, today announced the beginning ... fake-finger-detection (FFD) solution. The company, based in ... announcement at the three-day Connect:ID Expo, which began here ... NexID said version 2.0 of its SDK boosts ...
(Date:3/23/2015)... SoundView Technology Group issues a new research update following the ... wallet. SoundView was one of the selected user groups to provide ... in multiple scenarios and outlets. Soundview shares ... both debit and credit card payments.  Soundview ... meets their plans in 2015, it would push our IV ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... chief of naval research, told a packed house at the ... this week that he intends to bring officials from the ... basis, starting in 2013, to accelerate S&T efforts for the ... is phenomenal and very valuableand probably not enough," said Klunder ...
... Va.-- Adm. Mark Ferguson, vice chief of naval operations, ... Research) Naval S&T (science and technology) Partnership Conference and ... of innovative S&T programs being developed by the Navy. ... future for the Navy if sequestration, or automatic defense ...
... Nature , BioFrontiers Institute scientists at the University of ... target for anti-cancer drug development that is sitting at the ... scientists, laboratories collaborated to find a patch of amino acids ... end at this location, may prevent cancerous cells from reproducing. ...
Cached Biology News:In an uncertain world, Navy needs science and technology collaboration, chief says 2Leaner Navy looking at future technology, fleet size and sequestration 2CU-Boulder researchers uncover new target for cancer research 2
Physical Form: saline suspension with ethanol Particle Dim: mean particle size 50 μm Matrix: HyperD F. Useful for the removal of detergents from protein samples....
SDS-OutT SDS Precipitation Reagent...
... The Sciclone inL10 Workstation from Caliper ... technology, offering for the first time the ... to automatically react to changing conditions. ... changes in viscosity due to changes in ...
... Series of systems provide fast and ... discovery, genomics, proteomics and drug development ... three base configurations; Mini Workstation Series, ... All Staccato Application Series systems ...
Biology Products: